NO20070845L - Fremgangsmate for fremstilling av losartan - Google Patents
Fremgangsmate for fremstilling av losartanInfo
- Publication number
- NO20070845L NO20070845L NO20070845A NO20070845A NO20070845L NO 20070845 L NO20070845 L NO 20070845L NO 20070845 A NO20070845 A NO 20070845A NO 20070845 A NO20070845 A NO 20070845A NO 20070845 L NO20070845 L NO 20070845L
- Authority
- NO
- Norway
- Prior art keywords
- preparation
- losartan
- novel
- relates
- intermediates suitable
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C257/00—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines
- C07C257/10—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines
- C07C257/14—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines having carbon atoms of amidino groups bound to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
- C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D257/04—Five-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Den foreliggende oppfinnelsen gjelder en ny fremgangsmåte for fremstilling av losartan, et imidazolderivat med det kjemiske navnet 2-n-butyl-4-klor-5-hydroksymetyl-l-{[2'-(1H-tetrazol-5yl)bifenyl-4]metyl}irnidazol så vel som dens farmakologisk virksomme salter. Videre gjelder oppfinnelsen nye mellomprodukter som er egnet for fremstilling av losartan og også nye fremgangsmåter for fremstilling av mellomforbindelser som er egnet for fremstilling av losartan. Et aspekt av oppfinnelsen er en fremgangsmåte for fremstilling av en forbindelse med den generelle formel (1) som kan oppstå ved fremstillingen av losartan ifølge oppfinnelsen som mellomprodukt.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102005005047 | 2005-02-03 | ||
PCT/DE2006/000164 WO2006081807A2 (de) | 2005-02-03 | 2006-02-02 | Verfahren zur herstellung von losartan |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20070845L true NO20070845L (no) | 2007-11-02 |
Family
ID=36097110
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20070845A NO20070845L (no) | 2005-02-03 | 2007-02-14 | Fremgangsmate for fremstilling av losartan |
Country Status (13)
Country | Link |
---|---|
US (1) | US20090111994A1 (no) |
EP (2) | EP1844019B1 (no) |
CN (1) | CN101133035A (no) |
AT (2) | ATE441637T1 (no) |
CA (1) | CA2595962A1 (no) |
DE (1) | DE502006004733D1 (no) |
ES (1) | ES2332328T3 (no) |
IL (1) | IL184800A (no) |
NO (1) | NO20070845L (no) |
RU (1) | RU2412940C2 (no) |
SI (1) | SI1844019T1 (no) |
UA (1) | UA90131C2 (no) |
WO (1) | WO2006081807A2 (no) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20090018332A1 (en) * | 2007-06-28 | 2009-01-15 | Wyeth | Processes For Preparing Bicyclic Oxazine Carboxaldehyde and Beta-Lactamase Inhibitors |
KR101472686B1 (ko) * | 2013-07-09 | 2014-12-16 | 씨제이헬스케어 주식회사 | 벤즈이미다졸 유도체의 제조방법 |
CN103351352B (zh) * | 2013-07-15 | 2015-10-21 | 南通市华峰化工有限责任公司 | 一种5-苯基四氮唑新合成方法 |
CN113929666A (zh) * | 2021-09-30 | 2022-01-14 | 宁波美诺华药业股份有限公司 | 一种洛沙坦立体异构体杂质合成方法 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5671074A (en) * | 1979-11-12 | 1981-06-13 | Takeda Chem Ind Ltd | 1,2-disubstituted-4-halogenoimidazole-5-acetic acid derivative |
CA1334092C (en) | 1986-07-11 | 1995-01-24 | David John Carini | Angiotensin ii receptor blocking imidazoles |
US4820843A (en) * | 1987-05-22 | 1989-04-11 | E. I. Du Pont De Nemours And Company | Tetrazole intermediates to antihypertensive compounds |
CA1338238C (en) | 1988-01-07 | 1996-04-09 | David John Carini | Angiotensin ii receptor blocking imidazoles and combinations thereof with diuretics and nsaids |
US5411980A (en) * | 1989-07-28 | 1995-05-02 | Merck & Co., Inc. | Substituted triazolinones, triazolinethiones, and triazolinimines as angiotensin II antagonists |
DE4132633A1 (de) * | 1991-10-01 | 1993-04-08 | Bayer Ag | Cyclisch substituierte imidazolyl-propensaeurederivate |
CA2179067A1 (en) * | 1993-12-23 | 1995-06-29 | Gordon Creston Campbell, Jr. | Polymorphs of losartan and the process for the preparation of form ii of losartan |
ATE321039T1 (de) | 2002-04-29 | 2006-04-15 | Teva Pharma | Verfahren zur herstellung von losartan und losartan-kaliumsalz |
AU2003230193A1 (en) * | 2003-03-27 | 2004-10-18 | Hetero Drugs Limited | Novel crystalline forms of candesartan cilexetil |
-
2006
- 2006-02-02 RU RU2007129814/04A patent/RU2412940C2/ru not_active IP Right Cessation
- 2006-02-02 WO PCT/DE2006/000164 patent/WO2006081807A2/de active Application Filing
- 2006-02-02 US US11/883,972 patent/US20090111994A1/en not_active Abandoned
- 2006-02-02 SI SI200630452T patent/SI1844019T1/sl unknown
- 2006-02-02 DE DE502006004733T patent/DE502006004733D1/de active Active
- 2006-02-02 ES ES06705893T patent/ES2332328T3/es active Active
- 2006-02-02 CN CNA2006800069443A patent/CN101133035A/zh active Pending
- 2006-02-02 EP EP06705893A patent/EP1844019B1/de active Active
- 2006-02-02 CA CA002595962A patent/CA2595962A1/en not_active Abandoned
- 2006-02-02 EP EP09002883A patent/EP2080756A3/de not_active Withdrawn
- 2006-02-02 AT AT06705893T patent/ATE441637T1/de active
- 2006-02-02 UA UAA200709810A patent/UA90131C2/ru unknown
-
2007
- 2007-02-14 NO NO20070845A patent/NO20070845L/no not_active Application Discontinuation
- 2007-06-29 AT AT0040907U patent/AT9840U1/de not_active IP Right Cessation
- 2007-07-24 IL IL184800A patent/IL184800A/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
WO2006081807A2 (de) | 2006-08-10 |
IL184800A0 (en) | 2007-12-03 |
UA90131C2 (en) | 2010-04-12 |
EP1844019A2 (de) | 2007-10-17 |
US20090111994A1 (en) | 2009-04-30 |
ES2332328T3 (es) | 2010-02-02 |
EP2080756A2 (de) | 2009-07-22 |
EP2080756A3 (de) | 2011-02-16 |
ATE441637T1 (de) | 2009-09-15 |
WO2006081807A3 (de) | 2007-05-18 |
EP1844019B1 (de) | 2009-09-02 |
AT9840U1 (de) | 2008-04-15 |
DE502006004733D1 (de) | 2009-10-15 |
IL184800A (en) | 2011-06-30 |
CA2595962A1 (en) | 2006-08-10 |
SI1844019T1 (sl) | 2010-01-29 |
RU2412940C2 (ru) | 2011-02-27 |
RU2007129814A (ru) | 2009-03-10 |
CN101133035A (zh) | 2008-02-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2009044788A1 (ja) | ベンゾオキサジノン誘導体 | |
NO20050921L (no) | Nye fysiologisk aktive substanser | |
NO20091858L (no) | Hydrobenzamid derivater som inhibitorer av HSP90 | |
MX2009007334A (es) | Compuestos de amida del acido indol-3-carboxilico 6-substituido que tienen actividad antagonista biologica del receptor esfingosina-1-fosfato (s1p). | |
MX2010007588A (es) | Compuestos de amida del acido indol-3-carboxilico 6-substituido que tienen actividad antagonista biologica del receptor de esfingosina-1-fosfato (s1p). | |
WO2007112322A3 (en) | Indole compounds having sphingosine-1-phosphate (s1p) receptor agonist and/or antagonist biological activity | |
NO20076660L (no) | Fremgangsmate for fremstilling av rosuvastatin og mellomprodukter | |
TNSN08407A1 (en) | Organic compounds | |
NO20082338L (no) | Pyrimidinderivater for behandling av avvikende cellevekst | |
NO20082263L (no) | Organiske forbindelser | |
NO20065327L (no) | Fremgangsmate for fremstilling av derivarer av 5-'4-(2-hydroksy-propyl)-3,5-dihydro-3H'1, 2,4(triazin-2-yl)-benzamid. | |
NO20074188L (no) | Prosess for fremstilling av montelukast og mellomprodukter for det | |
NO20073701L (no) | Nye fremgangsmater for fremstilling av et 2H-kromen | |
NO20063268L (no) | Fremgangsmate til fremstilling av 1-(2S,3S)-2-benzhydryl-N-(5-tert-butyl-2-metoksybenzyl)quinuklidin-3-amin | |
WO2007032019A3 (en) | Process for preparing valsartan | |
EA200970604A1 (ru) | Новое промежуточное соединение и способ, используемый для получения {2-[1-(3,5-бис-трифторметилбензил)-5-пиридин-4-ил-1н-[1,2,3]триазол-4-ил]пиридин-3-ил}-(2-хлорфенил)метанона | |
NO20053753L (no) | Karboksylsyreforbindelser. | |
NO20070845L (no) | Fremgangsmate for fremstilling av losartan | |
NO20063111L (no) | Fremgangsmate for fremstilling av tiazolpyrimidiner | |
NO20076000L (no) | Aminosyrederivater | |
BRPI0607085A2 (pt) | derivados de oximas heterocìclicos, o respectivo processo de preparação e a respectiva utilização como agentes hipoglicemiantes e hipolipemiantes | |
MX2010009876A (es) | Nuevo proceso para la preparacion de derivados de acido ciclohexanocarboxilico por medio del derivado de ciclohexanocarboxamida correspondiente. | |
NO20082005L (no) | Syntese av renininhibitorer omfattende en cyklotilfoyelsesreaksjon | |
WO2008100651A3 (en) | Preparation of darifenacin and its salts | |
NO20065789L (no) | Cinnamidforbindelse |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |